by Sandip Das on 9 February 2024, 5 min read
The Indian stock market ended deep in the red, down 1 percent on February 8, 2024. At close, Sensex was down 723.57 points at 71,428.43 while Nifty declined 212.55 points and ended the session at 21,717.95.
Around 1057 stocks advanced and 1512 stocks declined while 88 stocks remained unchanged.
Among sectors, auto, bank, realty, capital goods, and FMCG shed 0.6-2 percent each. Oil & gas, power, Information Technology, and PSU Bank index added 0.3-2 percent each.
Trends on GIFT Nifty indicate a cautious start for Indian indices.
Wall Street’s major indexes rose on Thursday with the S&P hovering near the 5,000-point milestone as investors reacted to earnings reports and US jobs data, and the US dollar gained.
The Dow Jones Industrial Average rose 48.97 points, or 0.13%, to 38,726.33, the S&P 500 gained 2.85 points, or 0.06%, to 4,997.91. The Nasdaq Composite gained 37.07 points, or 0.24%, to 15,793.72.
Japanese shares hit 34-year highs on Friday. The Nikkei rose 1%, aided by a retreating yen that traded near its weakest in two months at 149.37 per dollar in the Asia morning. MSCI’s broadest index of Asia-Pacific shares outside Japan was flat and heading toward a 0.7% weekly rise to notch its longest weekly winning streak since June, according to a Reuters report.
Foreign institutional investors (FIIs) net sold shares worth Rs 4,933.78 crore. Domestic institutional investors (DIIs) purchased Rs 5,512.32 crore worth of stocks on February 8.
The NSE has added Aurobindo Pharma, Biocon, and Punjab National Bank to the F&O ban list for February 9.
Results today
Hero MotoCorp, Tata Power Company, Honasa Consumer, Zydus Lifesciences, Alkem Laboratories, Bandhan Bank, Campus Activewear, Cello World, DOMS Industries, Emami, Finolex Cables, Indian Railway Finance Corporation, MRF, The New India Assurance Company, Pfizer, PI Industries, Shree Renuka Sugars and Sundaram-Clayton.
Disclaimer: The content of this blog post is intended solely for informational purposes and should not be interpreted as investment or trading advice. The author does not assure the accuracy or completeness of the information presented. Any decisions or actions taken based on the content of this blog post are undertaken at your own risk.
Open Free Demat Account!
In just a few minutes, Simply provide some basic personal details, to get started.